159 related articles for article (PubMed ID: 4155802)
1. GABA blockade, dopamine and schizophrenia: experimental studies in the cat.
Stevens J; Wilson K; Foote W
Psychopharmacologia; 1974; 39(2):105-19. PubMed ID: 4155802
[No Abstract] [Full Text] [Related]
2. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.
Scheel-Krüger J
Acta Neurol Scand Suppl; 1986; 107():1-54. PubMed ID: 3014800
[No Abstract] [Full Text] [Related]
3. Removal of vestibular commissural inhibition by antagonists of GABA and glycine.
Precht W; Schwindt PC; Baker R
Brain Res; 1973 Nov; 62(1):222-6. PubMed ID: 4765112
[No Abstract] [Full Text] [Related]
4. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
Costall B; Naylor RJ
Eur J Pharmacol; 1974 Dec; 29(2):206-22. PubMed ID: 4613561
[No Abstract] [Full Text] [Related]
5. The effects of haloperidol and clozapine on circling induced by electrical stimulation of the substantia nigra and the ventromedial tegmentum.
Roffman M; Bernard PS; Dawson KM; Sobiski RE; Saelens JK
Neuropharmacology; 1978 Nov; 17(11):943-6. PubMed ID: 569257
[No Abstract] [Full Text] [Related]
6. Picrotoxin-like action of bicuculline.
Banna NR; Naccache A; Jabbur SJ
Eur J Pharmacol; 1972 Feb; 17(2):301-2. PubMed ID: 4402098
[No Abstract] [Full Text] [Related]
7. Gamma-aminobutyric acid antagonists in crustacea.
McLennan H
Can J Physiol Pharmacol; 1973 Oct; 51(10):774-5. PubMed ID: 4753290
[No Abstract] [Full Text] [Related]
8. Effects of picrotoxin and bicuculline on the excitation and inhibition of Renshaw cells.
Piercey MF; Goldfarb J; Ryall RW
Neuropharmacology; 1973 Oct; 12(10):975-82. PubMed ID: 4750565
[No Abstract] [Full Text] [Related]
9. Effects of bicuculline on central inhibition.
Huffman RD; McFadin LS
Neuropharmacology; 1972 Nov; 11(6):789-99. PubMed ID: 4638180
[No Abstract] [Full Text] [Related]
10. Glycine and GABA as inhibitory transmitters in the medullary reticular formation. Studies involving intra- and extra-cellular recording.
Tebécis AK; Ishikawa T
Pflugers Arch; 1973 Feb; 338(3):273-8. PubMed ID: 4736725
[No Abstract] [Full Text] [Related]
11. The effect of the GABA antagonists bicuculline and picrotoxin on primary afferent terminal excitability.
Levy RA; Anderson EG
Brain Res; 1972 Aug; 43(1):171-80. PubMed ID: 4340463
[No Abstract] [Full Text] [Related]
12. Bicuculline and picrotoxin sensitive inhibition in interpositus neurones of cat.
Kawaguchi S; Ono T
Brain Res; 1973 Aug; 58(1):260-5. PubMed ID: 4354377
[No Abstract] [Full Text] [Related]
13. Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia.
Glenthøj B; Mogensen J; Laursen H; Holm S; Hemmingsen R
Brain Res; 1993 Aug; 619(1-2):39-54. PubMed ID: 8374792
[TBL] [Abstract][Full Text] [Related]
14. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
Di Chiara G; Morelli M; Porceddu ML; Gessa GL
Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
[No Abstract] [Full Text] [Related]
15. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
Johnson AM; Vigouret JM; Loew DM
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
[No Abstract] [Full Text] [Related]
16. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
Olianas MC; De Montis GM; Mulas G; Tagliamonte A
Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
[No Abstract] [Full Text] [Related]
17. Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.
Costall B; Naylor RJ; Pettit JC
Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(2):103-26. PubMed ID: 4281065
[No Abstract] [Full Text] [Related]
18. Actions of GABA, picrotoxin and bicuculline on adrenal medulla.
Sangiah S; Borowitz JL; Yim GK
Eur J Pharmacol; 1974 Jun; 27(1):130-5. PubMed ID: 4850400
[No Abstract] [Full Text] [Related]
19. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
[TBL] [Abstract][Full Text] [Related]
20. Effects of kainic acid lesions of the striatum on self-stimulation in the substantia nigra and ventral tegmental area.
Phillips AG; LePiane FG; Fibiger HC
Behav Brain Res; 1982 Jul; 5(3):297-310. PubMed ID: 6889435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]